HilleVax appoints McLoughlin as Chief Operating Officer

HilleVax (HLVX) announced the appointment of Sean McLoughlin as Chief Operating Officer. As part of a planned transition in connection with McLoughlin’s appointment, Co-founder and current Chief Operating Officer Dr. Aditya Kohli will remain a full-time executive with the company as Chief Business Officer, where he will be responsible for business development and corporate strategy. McLoughlin has three decades of commercial and operational experience in vaccines, most recently as the Global Vaccine Commercialization Lead, RSV at GSK (GSK).